These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37866544)

  • 1. LINC00926 promotes progression of renal cell carcinoma via regulating miR-30a-5p/SOX4 axis and activating IFNγ-JAK2-STAT1 pathway.
    Du L; Wang B; Wu M; Chen W; Wang W; Diao W; Ding M; Chen W; Cao W; Guo H; Zhang G
    Cancer Lett; 2023 Dec; 578():216463. PubMed ID: 37866544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
    Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
    J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA TINCR impairs the efficacy of immunotherapy against breast cancer by recruiting DNMT1 and downregulating MiR-199a-5p via the STAT1-TINCR-USP20-PD-L1 axis.
    Wang Q; Li G; Ma X; Liu L; Liu J; Yin Y; Li H; Chen Y; Zhang X; Zhang L; Sun L; Ai J; Xu S
    Cell Death Dis; 2023 Feb; 14(2):76. PubMed ID: 36725842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINC00926 is involved in hypoxia-induced vascular endothelial cell dysfunction
    Jiang Y; Xu CH; Zhao Y; Ji YH; Wang XT; Liu Y
    Eur J Histochem; 2023 Jan; 67(1):. PubMed ID: 36647631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA CYTOR modulates cancer progression through miR-136-5p/MAT2B axis in renal cell carcinoma.
    Wang D; Zhu X; Siqin B; Ren C; Yi F
    Toxicol Appl Pharmacol; 2022 Jul; 447():116067. PubMed ID: 35597301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depletion of lncRNA MALAT1 inhibited sunitinib resistance through regulating miR-362-3p-mediated G3BP1 in renal cell carcinoma.
    Wang Z; Chang X; Zhu G; Gao X; Chang L
    Cell Cycle; 2020 Aug; 19(16):2054-2062. PubMed ID: 32663095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA MIAT targets miR-411-5p/STAT3/PD-L1 axis mediating hepatocellular carcinoma immune response.
    Zhang X; Pan B; Qiu J; Ke X; Shen S; Wang X; Tang N
    Int J Exp Pathol; 2022 Jun; 103(3):102-111. PubMed ID: 35429078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of lncRNA HOTAIR alleviates RCC angiogenesis through regulating miR-126/EGFL7 axis.
    Guo YP; Wang ZF; Li N; Lei QQ; Cheng Q; Shi LG; Zhou SL; Wang XH; Sun Y; Kong LF
    Am J Physiol Cell Physiol; 2021 May; 320(5):C880-C891. PubMed ID: 33502949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA RCAT1 promotes tumor progression and metastasis via miR-214-5p/E2F2 axis in renal cell carcinoma.
    Guo R; Zou B; Liang Y; Bian J; Xu J; Zhou Q; Zhang C; Chen T; Yang M; Wang H; Pei F; Xu Z
    Cell Death Dis; 2021 Jul; 12(7):689. PubMed ID: 34244473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-Regulation of ID2-AS1 Alleviates the Neuronal Injury Induced by 1-Methy1-4-Phenylpyridinium in Human Neuroblastoma Cell Line SH-SY5Y Cells Through Regulating miR-199a-5p/IFNAR1/JAK2/STAT1 Axis.
    Xu F; Wang H; Tian J; Xu H
    Neurochem Res; 2021 Aug; 46(8):2192-2203. PubMed ID: 34050453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA HOTTIP promotes renal cell carcinoma progression through the regulation of the miR-615/IGF-2 pathway.
    Wang Q; Wu G; Zhang Z; Tang Q; Zheng W; Chen X; Chen F; Li Q; Che X
    Int J Oncol; 2018 Nov; 53(5):2278-2288. PubMed ID: 30226576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-375 inhibits IFN-γ-induced programmed death 1 ligand 1 surface expression in head and neck squamous cell carcinoma cells by blocking JAK2/STAT1 signaling.
    Wu Q; Zhao Y; Sun Y; Yan X; Wang P
    Oncol Rep; 2018 Mar; 39(3):1461-1468. PubMed ID: 29328389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipopolysaccharide facilitates immune escape of hepatocellular carcinoma cells via m6A modification of lncRNA MIR155HG to upregulate PD-L1 expression.
    Peng L; Pan B; Zhang X; Wang Z; Qiu J; Wang X; Tang N
    Cell Biol Toxicol; 2022 Dec; 38(6):1159-1173. PubMed ID: 35438468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA SNHG17 promotes tumor progression and predicts poor survival in human renal cell carcinoma via sponging miR-328-3p.
    Wu J; Dong G; Liu T; Zhang S; Sun L; Liang W
    Aging (Albany NY); 2021 Sep; 13(17):21232-21250. PubMed ID: 34497156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA SNHG1 regulates immune escape of renal cell carcinoma by targeting miR-129-3p to activate STAT3 and PD-L1.
    Tian P; Wei JX; Li J; Ren JK; Yang JJ
    Cell Biol Int; 2021 Jul; 45(7):1546-1560. PubMed ID: 33739543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LINC02535/miR-30a-5p/GALNT3 axis contributes to lung adenocarcinoma progression via the NF- κ B signaling pathway.
    Li Y; Zhao J; Zhang W; Wang A; Jiao M; Cai X; Zhu J; Liu Z; Huang JA
    Cell Cycle; 2022 Dec; 21(23):2455-2470. PubMed ID: 35852407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-conding RNA LOXL1-AS1 sponges miR-589-5p to up-regulate CBX5 expression in renal cell carcinoma.
    Wu C; Zhang J
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33185692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA circSDHC serves as a sponge for miR-127-3p to promote the proliferation and metastasis of renal cell carcinoma via the CDKN3/E2F1 axis.
    Cen J; Liang Y; Huang Y; Pan Y; Shu G; Zheng Z; Liao X; Zhou M; Chen D; Fang Y; Chen W; Luo J; Zhang J
    Mol Cancer; 2021 Jan; 20(1):19. PubMed ID: 33468140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Interferon Signaling Is Regulated by a lncRNA INCR1 Transcribed from the PD-L1 Locus.
    Mineo M; Lyons SM; Zdioruk M; von Spreckelsen N; Ferrer-Luna R; Ito H; Alayo QA; Kharel P; Giantini Larsen A; Fan WY; Auduong S; Grauwet K; Passaro C; Khalsa JK; Shah K; Reardon DA; Ligon KL; Beroukhim R; Nakashima H; Ivanov P; Anderson PJ; Lawler SE; Chiocca EA
    Mol Cell; 2020 Jun; 78(6):1207-1223.e8. PubMed ID: 32504554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase 2 knockout suppresses immune escape of triple-negative breast cancer cells via downregulating PD-L1 expression.
    Xu P; Xiong W; Lin Y; Fan L; Pan H; Li Y
    Cell Death Dis; 2021 Aug; 12(8):779. PubMed ID: 34365463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.